scispace - formally typeset
P

Peter W. Andrews

Researcher at University of Sheffield

Publications -  286
Citations -  22367

Peter W. Andrews is an academic researcher from University of Sheffield. The author has contributed to research in topics: Embryonic stem cell & Cellular differentiation. The author has an hindex of 71, co-authored 280 publications receiving 21323 citations. Previous affiliations of Peter W. Andrews include East Sussex County Council & Wistar Institute.

Papers
More filters
Journal ArticleDOI

Embryonic stem cells and retinal repair.

TL;DR: This review examines the potential of embryonic stem cells for use in the treatment of retinal diseases involving photoreceptors and retinal pigment epithelium and considers both the potential barriers to transplant integration in the retina itself and the remodelling in host visual centres that is known to accompany retinal dystrophy.
Journal ArticleDOI

Ibuprofen Inhibits Survival of Bladder Cancer Cells by Induced Expression of the p75NTR Tumor Suppressor Protein

TL;DR: Observations suggest that p75NTR is an important upstream modulator of the anticancer effects of NSAIDs and that ibuprofen induction of the p 75NTR protein establishes an alternate mechanism by which ib uprofen may exert an anticancer effect.
Journal ArticleDOI

Cell-Cell Signaling Through NOTCH Regulates Human Embryonic Stem Cell Proliferation

TL;DR: The results indicate that cell‐cell signaling through the NOTCH system provides a critical cue for the proliferation of human EC and ES cell in vitro.
Journal ArticleDOI

Culture adaptation of embryonic stem cells echoes germ cell malignancy.

TL;DR: Understanding the mechanisms that drive culture adaptation of human embryonic stem cells may also provide insights into the development and progression of germ cell tumours.
Journal ArticleDOI

Time-Lapse Analysis of Human Embryonic Stem Cells Reveals Multiple Bottlenecks Restricting Colony Formation and Their Relief upon Culture Adaptation

TL;DR: Using time-lapse imaging, a series of bottlenecks that restrict growth of early-passage human embryonic stem cells (hESCs) and that are relieved by karyotypically abnormal variants that are selected by prolonged culture are identified.